{
  "id": 828314,
  "title": "How iX Biopharma turned conviction into opportunity",
  "url": "https://urgent.news/2026/08/14/how-ix-biopharma-turned-conviction-into-opportunity",
  "topic": "business",
  "section": "Business",
  "published": "2026-08-14T01:25:15.000Z",
  "source": {
    "name": "Channel News Asia",
    "slug": "channel-news-asia",
    "url": "https://www.channelnewsasia.com/brand-studio/how-ix-biopharma-turned-conviction-opportunity-6297431"
  },
  "original_language": "en",
  "account": null,
  "summary": "After losing a key licensing partner, the Singapore pharmaceutical company continued advancing its lead drug programme. That persistence opened new pathways to commercialisation – and unlocked value beyond the laboratory.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}